Klaus H.W. Böker

4.1k total citations
82 papers, 3.1k citations indexed

About

Klaus H.W. Böker is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Klaus H.W. Böker has authored 82 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Epidemiology, 50 papers in Hepatology and 19 papers in Surgery. Recurrent topics in Klaus H.W. Böker's work include Liver Disease Diagnosis and Treatment (37 papers), Hepatitis C virus research (27 papers) and Hepatitis B Virus Studies (22 papers). Klaus H.W. Böker is often cited by papers focused on Liver Disease Diagnosis and Treatment (37 papers), Hepatitis C virus research (27 papers) and Hepatitis B Virus Studies (22 papers). Klaus H.W. Böker collaborates with scholars based in Germany, United States and Estonia. Klaus H.W. Böker's co-authors include Michael P. Manns, Mathias Bähr, Hans L. Tillmann, Christian Trautwein, R. Pichlmayr, Uwe J.F. Tietge, Michael P. Manns, Jürgen Klempnauer, Jens Rosenau and O. Selberg and has published in prestigious journals such as The Lancet, Gastroenterology and PLoS ONE.

In The Last Decade

Klaus H.W. Böker

80 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaus H.W. Böker Germany 32 2.1k 2.0k 704 321 216 82 3.1k
Paloma Jara Spain 34 1.7k 0.8× 1.7k 0.8× 1.1k 1.5× 38 0.1× 204 0.9× 147 3.1k
Satoshi Mochida Japan 31 1.9k 0.9× 1.4k 0.7× 891 1.3× 64 0.2× 27 0.1× 144 3.0k
Carlo Umberto Casciani Italy 28 444 0.2× 461 0.2× 690 1.0× 142 0.4× 348 1.6× 146 2.4k
Adam Testro Australia 20 526 0.3× 531 0.3× 402 0.6× 252 0.8× 119 0.6× 113 1.3k
Yvon Calmus France 29 1.7k 0.8× 1.1k 0.5× 1.7k 2.4× 54 0.2× 980 4.5× 109 3.1k
Luis A. Balart United States 23 2.9k 1.4× 2.7k 1.4× 448 0.6× 108 0.3× 31 0.1× 64 4.0k
Kyle Soltys United States 29 667 0.3× 415 0.2× 1.4k 2.0× 107 0.3× 583 2.7× 93 2.5k
Ayano Inui Japan 26 977 0.5× 1.1k 0.5× 423 0.6× 126 0.4× 14 0.1× 163 2.0k
Charalambos G. Antoniades United Kingdom 22 1.4k 0.7× 1.0k 0.5× 477 0.7× 49 0.2× 38 0.2× 30 2.3k
Yun Ma United Kingdom 37 3.0k 1.4× 2.5k 1.3× 884 1.3× 63 0.2× 53 0.2× 73 4.3k

Countries citing papers authored by Klaus H.W. Böker

Since Specialization
Citations

This map shows the geographic impact of Klaus H.W. Böker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus H.W. Böker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus H.W. Böker more than expected).

Fields of papers citing papers by Klaus H.W. Böker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus H.W. Böker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus H.W. Böker. The network helps show where Klaus H.W. Böker may publish in the future.

Co-authorship network of co-authors of Klaus H.W. Böker

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus H.W. Böker. A scholar is included among the top collaborators of Klaus H.W. Böker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus H.W. Böker. Klaus H.W. Böker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rossol, S., Christian Krauth, Peter Buggisch, et al.. (2022). Real‐world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R). Zeitschrift für Gastroenterologie. 61(5). 489–503. 3 indexed citations
2.
3.
Heidrich, Benjamin, Steffen B. Wiegand, Peter Buggisch, et al.. (2014). Treatment of Naïve Patients with Chronic Hepatitis C Genotypes 2 and 3 with Pegylated Interferon Alpha and Ribavirin in a Real World Setting: Relevance for the New Era of DAA. PLoS ONE. 9(10). e108751–e108751. 13 indexed citations
4.
Böker, Klaus H.W. & Tobias Welte. (2008). Lungenbeteiligung bei Lebererkrankungen. DMW - Deutsche Medizinische Wochenschrift. 120(30). 1053–1056.
5.
Ockenga, Johann, Uwe J.F. Tietge, Klaus H.W. Böker, et al.. (2007). Distinct roles of free leptin, bound leptin and soluble leptin receptor during the metabolic‐inflammatory response in patients with liver cirrhosis. Alimentary Pharmacology & Therapeutics. 25(11). 1301–1309. 10 indexed citations
6.
Tietge, Uwe J.F., et al.. (2003). Hepatic amino-acid metabolism in liver cirrhosis and in the long-term course after liver transplantation. Transplant International. 16(1). 1–8. 20 indexed citations
7.
Tillmann, Hans L., Christian Trautwein, Volker Kliem, et al.. (2001). Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage liver disease. Gut. 48(5). 714–718. 53 indexed citations
8.
Böker, Klaus H.W.. (2001). Akutes Leberversagen. Der Internist. 42(4). 545–563. 3 indexed citations
9.
Böker, Klaus H.W., et al.. (2000). Tissue inhibitors of metalloproteinases in liver and serum/plasma in chronic active hepatitis C and HCV-induced cirrhosis.. PubMed. 47(33). 812–9. 25 indexed citations
10.
Müller, Manfred J., Joachim Böttcher, O. Selberg, et al.. (1999). Hypermetabolism in clinically stable patients with liver cirrhosis. American Journal of Clinical Nutrition. 69(6). 1194–1201. 179 indexed citations
11.
Tietge, Uwe J.F., Christof Schöfl, Kenneth Ocran, et al.. (1998). Hepatoma With Severe Non-Islet Cell Tumor Hypoglycemia. The American Journal of Gastroenterology. 93(6). 997–1000. 20 indexed citations
12.
Caselitz, M, H. Link, H. Maschek, et al.. (1997). Hepatitis B associated liver failure following bone marrow transplantation. Journal of Hepatology. 27(3). 572–577. 44 indexed citations
13.
Böker, Klaus H.W., Mathias Bähr, H. Maschek, et al.. (1997). Long–Term Outcome of Hepatitis C Virus Infection After Liver Transplantation. Hepatology. 25(1). 203–210. 174 indexed citations
14.
Hoffmann, Jörg, Mathias Bähr, Uwe J.F. Tietge, et al.. (1996). Detection of a soluble form of the human adhesion receptor lymphocyte function-associated antigen-3 (LFA-3) in patients with chronic liver disease. Journal of Hepatology. 25(4). 465–473. 8 indexed citations
15.
Lichtinghagen, Ralf, et al.. (1995). Expression Pattern of Matrix Metalloproteinases in Human Liver. Clinical Chemistry and Laboratory Medicine (CCLM). 33(2). 65–72. 44 indexed citations
16.
Tillmann, Hans L., Christian Trautwein, Diana L. Walker, et al.. (1995). Clinical relevance of mutations in the precore genome of the hepatitis B virus.. Gut. 37(4). 568–573. 37 indexed citations
17.
Bader, Augustinus, Erich Knop, Nils R. Frühauf, et al.. (1995). Reconstruction of Liver Tissue In Vitro: Geometry of Characteristic Flat Bed, Hollow Fiber, and Spouted Bed Bioreactors with Reference to the In Vivo Liver. Artificial Organs. 19(9). 941–950. 42 indexed citations
18.
Knop, Erich, Augustinus Bader, Klaus H.W. Böker, R Pichlmayr, & Karl‐Friedrich Sewing. (1995). Ultrastructural and functional differentiation of hepatocytes under long‐term culture conditions. The Anatomical Record. 242(3). 337–349. 48 indexed citations
19.
Oldhafer, Karl J., et al.. (1994). Auxiliary partial orthotopic liver transplantation for acute liver failure: the Hannover experience.. PubMed. 181–7. 17 indexed citations
20.
Rehermann, Barbara, Christian Trautwein, Klaus H.W. Böker, & Michael P. Manns. (1992). Interleukin-6 in liver diseases. Journal of Hepatology. 15(3). 277–280. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paloma Jara Breakdown of academic impact, for papers by Satoshi Mochida Breakdown of academic impact, for papers by Carlo Umberto Casciani Breakdown of academic impact, for papers by Adam Testro Breakdown of academic impact, for papers by Yvon Calmus Breakdown of academic impact, for papers by Luis A. Balart Breakdown of academic impact, for papers by Kyle Soltys Breakdown of academic impact, for papers by Ayano Inui Breakdown of academic impact, for papers by Charalambos G. Antoniades Breakdown of academic impact, for papers by Yun Ma
Rankless by CCL
2026